Ju Won Kim

654 total citations
43 papers, 351 citations indexed

About

Ju Won Kim is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Ju Won Kim has authored 43 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 10 papers in Cancer Research and 9 papers in Molecular Biology. Recurrent topics in Ju Won Kim's work include Cancer Genomics and Diagnostics (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Energetic Materials and Combustion (4 papers). Ju Won Kim is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Colorectal Cancer Treatments and Studies (5 papers) and Energetic Materials and Combustion (4 papers). Ju Won Kim collaborates with scholars based in South Korea, Japan and United States. Ju Won Kim's co-authors include Kyong Hwa Park, Si Young Song, Hye Won Chung, Jae Bock Chung, Yoon Ji Choi, Yeul Hong Kim, Stanley J. Roux, Soo Hwan Kim, Seungmin Bang and Sejin Kwon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ju Won Kim

40 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Won Kim South Korea 11 116 91 80 54 45 43 351
Shuoyao Qu China 11 25 0.2× 80 0.9× 28 0.3× 120 2.2× 47 1.0× 26 349
Jianguo Gao China 10 35 0.3× 82 0.9× 12 0.1× 31 0.6× 40 0.9× 51 278
Liang Jin China 12 109 0.9× 200 2.2× 23 0.3× 119 2.2× 44 1.0× 44 461
Shujia Chen China 11 43 0.4× 130 1.4× 10 0.1× 63 1.2× 15 0.3× 30 317
Isao Sekiguchi Japan 11 69 0.6× 122 1.3× 10 0.1× 25 0.5× 61 1.4× 53 487
Huiting Xu China 11 72 0.6× 55 0.6× 27 0.3× 37 0.7× 20 0.4× 33 269
Manish T. Raiji United States 10 261 2.3× 94 1.0× 28 0.3× 39 0.7× 91 2.0× 14 414
Ryusuke Suzuki Japan 7 11 0.1× 114 1.3× 73 0.9× 20 0.4× 53 1.2× 37 289

Countries citing papers authored by Ju Won Kim

Since Specialization
Citations

This map shows the geographic impact of Ju Won Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Won Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Won Kim more than expected).

Fields of papers citing papers by Ju Won Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Won Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Won Kim. The network helps show where Ju Won Kim may publish in the future.

Co-authorship network of co-authors of Ju Won Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Won Kim. A scholar is included among the top collaborators of Ju Won Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Won Kim. Ju Won Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ju Won, et al.. (2024). Transcriptomic analysis of cellular senescence induced by ectopic expression of ATF6α in human breast cancer cells. PLoS ONE. 19(10). e0309749–e0309749. 1 indexed citations
2.
3.
Hong, Jin Hwa, Ju Won Kim, Seung‐Cheol Choi, et al.. (2024). Investigating miR-6880-5p in extracellular vesicle from plasma as a prognostic biomarker in endocrine therapy-treated castration-resistant prostate cancer. BMC Cancer. 24(1). 909–909. 3 indexed citations
4.
Kim, Ju Won, Juneyoung Lee, Soo Hyun Lee, et al.. (2024). The clinical effect of an electric massage chair on chemotherapy-induced nausea and vomiting in cancer patients: randomized phase II cross-over trial. BMC Complementary Medicine and Therapies. 24(1). 163–163.
5.
Kim, Ju Won, et al.. (2024). Machine Learning–Based Prognostic Gene Signature for Early Triple-Negative Breast Cancer. Cancer Research and Treatment. 57(3). 731–740. 1 indexed citations
6.
Kim, Ju Won & Hongjae Kang. (2024). Rapid startup of hydroxyethylhydrazinium nitrate ionic monopropellant thruster using rotating arc plasma jet. Advances in Space Research. 75(4). 3982–3993. 3 indexed citations
7.
Song, Sung Eun, Ok Hee Woo, Yongwon Cho, et al.. (2023). Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI. Academic Radiology. 30. S25–S37. 9 indexed citations
8.
Lee, Jiyun, Sehhoon Park, Hyun Ae Jung, et al.. (2023). A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas. Cancer. 129(19). 2966–2974. 9 indexed citations
9.
Kim, Ju Won, Hyo Jin Lee, K. Jason, et al.. (2023). 613 A phase II study of nivolumab in patients with genetic alterations in DNA damage repair and response who progressed after standard treatment for metastatic solid cancers (KM-06). SHILAP Revista de lepidopterología. A698–A698. 1 indexed citations
10.
Kim, Ju Won, Jimi Choi, Seung Gyu Yun, et al.. (2022). Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation. Cancer Research and Treatment. 55(1). 155–166. 1 indexed citations
11.
Kim, Ju Won, Soo Hyun Lee, Hye Sook Kim, et al.. (2021). Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13). Cytokine. 142. 155487–155487. 8 indexed citations
12.
Lee, Soo Hyun, Min Ja Kim, Yoon Ji Choi, et al.. (2020). Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea. European Journal of Cancer. 136. 69–75. 10 indexed citations
13.
Choi, Sun-Ho, Minhyeok Lee, Young Soo Park, et al.. (2020). Clinical Implication of Concordant or Discordant Genomic Profiling between Primary and Matched Metastatic Tissues in Patients with Colorectal Cancer. Cancer Research and Treatment. 52(3). 764–778. 6 indexed citations
14.
Lee, Soo Hyun, Jae Sook Sung, Ju Won Kim, et al.. (2020). Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project. Cancer Research and Treatment. 53(1). 123–130. 12 indexed citations
15.
Kim, Ju Won, Yoon Ji Choi, Youn Seon Choi, et al.. (2019). Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study. BMC Palliative Care. 18(1). 84–84. 14 indexed citations
16.
Kim, Hye Sook, Ju Won Kim, Yoon Ji Choi, et al.. (2016). Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea. Oncology. 91(5). 274–282. 17 indexed citations
17.
Lee, Chang Youn, et al.. (2012). Cemento-Ossifying Fibroma in the Maxilla: A Case Report. 34(3). 215–219. 2 indexed citations
18.
Kim, Ju Won, et al.. (2008). Expressed Sequence Tags Analysis of Black Rockfish (Sebastes schlegeli) Peripheral Leukocytes Stimulated with Con A/PMA or LPS. 21(2). 129–137. 1 indexed citations
19.
Lee, Young Mi, et al.. (2005). A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog. Journal of Veterinary Science. 6(4). 363–363.
20.
Chung, Hye Won, Seungmin Bang, Seung Woo Park, et al.. (2004). A prospective randomized study of gemcitabine with doxifluridine versus paclitaxel with doxifluridine in concurrent chemoradiotherapy for locally advanced pancreatic cancer. International Journal of Radiation Oncology*Biology*Physics. 60(5). 1494–1501. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026